Xue-ke Zhao-Xueke
No. 9 Beijing Road
Guiyang, 550004, China
Guiyang, 550004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
M2 macrophage-derived apoptotic vesicles alleviate liver fibrosis via miR-1224-5p-mediated inhibition of the SP1/TGF-β pathway in hepatic stellate cells.
Journal: Journal of nanobiotechnology
Published: October 29, 2025
FAK-TRIM25 promotes HSC activation and glycolysis by inhibiting c-Myc ubiquitination via FBXW7.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 02, 2025
Correction: Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.
Journal: Hepatology international
Published: March 27, 2025
FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation.
Journal: World journal of gastroenterology
Published: March 21, 2025
Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis.
Journal: Scientific reports
Published: September 11, 2024
TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis.
Journal: Clinical epigenetics
Published: August 05, 2024
Nintedanib attenuates NLRP3 inflammasome-driven liver fibrosis by targeting Src signaling.
Journal: International immunopharmacology
Published: July 19, 2024
Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 03, 2024
Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.
Journal: Hepatology international
Published: March 28, 2023
MIA3 promotes the degradation of GSH (glutathione) by binding to CHAC1, thereby promoting the progression of hepatocellular carcinoma.
Journal: Molecular and cellular biochemistry
Published: March 21, 2023
Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway.
Journal: Nutrition & metabolism
Published: March 23, 2022
Last Updated: 09/26/2026